Sudden cardiac death of a young athlete is a rare but devastating event. The pre-participation exam consists of a history and physical, however the sensitivity of this is poor. This talk will review the evaluation recommended by the American Heart Association, the American Academy of Pediatrics, the American Family Physician, as well as the more controversial widespread screening with electrocardiogram and limited focus cardiac ultrasound.
Dr. Goodman will discuss clinical concerns regarding common thrombotic issues. He will review the causes and the utility of hypercoaguable states. He will discuss the limits of diagnostic testing for idiopathic thrombosis and talk about the treatment options for this condition.
Until the advent of the COMPASS trial, secondary prevention in patients with peripheral artery disease consisted of either aspirin or clopidogrel monotherapy. A new era is emerging in which, by adding low-dose DOACs to low-dose aspirin, medical therapy may reduce the need for major vascular surgery or endovascular procedures. In this Video Webcast, the faculty will discuss the latest evidence, indications, and guideline-based utilization of dual antiplatelet therapy. In addition to an in-depth look at PAD therapy, participants in this session will receive insights on the latest in secondary prevention options for ESUS and a review of proper dosing for long-term anticoagulation to prevent recurrent events in patients with venous thromboembolic disease.
This session will focus on incorporating the latest advances in anticoagulation for stroke prevention in atrial fibrillation and acute treatment and long-term prevention of venous thromboembolism. The expanding role of the non-vitamin K oral anticoagulants will be discussed in the context of pivotal, landmark randomized controlled trials. Dr. Beckman will also discuss the management of bleeding in patients on NOACs.
Despite significant advances in heart failure management, including pharmacotherapy and devices, treating this complex condition remains challenging. This activity discusses the differences in pathophysiology of heart failure with reduced and preserved ejection fraction and the different treatment approaches required for each condition. Novel agents under investigation that hold promise for treatment of this population are also discussed.
Dr. Andrew Bomback uses a case vignette to illustrate the work-up of a patient who presents with secondary hypertension in order to differentiate between hypertensive urgency and hypertensive emergency and formulate appropriate interventions.
Hypertension is a chronic condition, with long term management strategies. On occasion, however, rather than evaluating and managing chronic hypertension, the clinical is faced with a hypertensive crisis. Understanding how and when to respond to such crises is of paramount importance in order to reduce morbidity and mortality in such situations. Dr. Watson will discuss how to perform an early evaluation of clinical symptoms and evaluation for end-organ damage as it is critical to determine the appropriate management.
In this activity, Dr. Anderson answers some common questions encountered by primary care physicians in the management and care of patients with heart failure. Some of the topics discussed include the use of cardiac MRI, appropriate use of biomarkers and the recommended drugs to be used in patients with heart failure.
This activity reviews diagnostic and therapeutic approaches for patients with atrial arrhythmias, including supraventricular tachycardia, atrial flutter and atrial fibrillation. Faculty will discuss the safety and efficacy of catheter ablation compared with pharmacologic therapy, as well as recent data on how risk factor modification (hypertension, obesity, exercise, sleep apnea, alcohol) can be used as a means to reduce the recurrence rate for atrial fibrillation.
In this activity, Dr. Blaine will review the current epidemiology of hypertension in the United States and discuss how advocating for self-measured blood pressure monitoring can help the patients in your practice. He will discuss aspects of choosing devices, clinical support strategies and provide practical advice on applying this program in your practice.
This talk will discuss venous anatomy, the pathophysiology of venous disease and the modern treatment of venous insufficiency and varicose veins. Special attention is also given to the treatment of venous ulceration, as well as issues related to venous disease and the elderly.